Ten-year experience with the Perceval S sutureless prosthesis: lessons learned and future perspectives
- PMID: 29963376
- PMCID: PMC5994436
- DOI: 10.21037/jovs.2018.03.10
Ten-year experience with the Perceval S sutureless prosthesis: lessons learned and future perspectives
Abstract
Aortic stenosis has traditionally been addressed with surgical aortic valve replacement (AVR). In recent years, several technologies have emerged as alternative treatment methods for aortic valve disease. Among them, the Perceval (LivaNova, London, UK) is a sutureless valve that has been used in clinical practice for over 10 years. It has been implanted in over 20,000 patients worldwide. With nearly 600 Perceval implants since 2011, the Montreal Heart Institute has developed a worldwide expertise with this technology. In this article, we provide an overview of the clinical data currently available in the literature and discuss the lessons we have learned from our experience with the Perceval prosthesis.
Keywords: Perceval S prosthesis; Sutureless valves; aortic valve replacement (AVR).
Conflict of interest statement
Conflicts of Interest: D Bouchard is a proctor for LivaNova, London, UK. The other authors have no conflicts of interest to declare.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources